|
|
| (11) | Number of the document | C 1320540 |
| (68) | Number of the document | 1320540 |
| (21) | Application number for Supplementary Protection Certificate | PA 2012 003 |
| (22) | Date of filing the application | 2012-03-16 |
| (41) | Date of publication of the application | 2012-04-25 |
| Date of publication of SPC | 2012-09-25 | |
| (24) | Date of coming into effect of SPC | 2021-09-01 |
| (71) |
VERTEX PHARMACEUTICALS INCORPORATED,
130 Waverly Street, Cambridge, MA 02139,
US
|
| (73) |
VERTEX PHARMACEUTICALS INCORPORATED,
130 Waverly Street, Cambridge, MA 02139,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (93) | EU/1/11/720/001, 2011-09-19 |
| (94) | 2026-09-01 |
| (95) | Telaprevirum |
| SPC lapsed (non-payment of fees for the main patent) |